author-photo

Miguel A. Villalona-Calero

University of Texas at Austin

11

Papers

325

Citations

Citation Trend

Filter By

Papers (9) Sort By

Journal Conference Others

Phase II trial of huN901-DM1 in patients with relapsed small cell lung cancer (SCLC) and CD56-positive small cell carcinoma

2007 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (17)
Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function

2006 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (84)
Phase I dose-finding and pharmacokinetic trial of irinotecan (CPT-11) administered every two weeks

2001 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (41)
Phase I a nd P harmacologic S tudy o f P N401 a nd F luorouracil in P atients W ith A dvanced S olid M alignancies

2000
Show All
- Source
- Cite
- Save
Citations (0)
Phase I and Pharmacokinetic Study of Irofulven, a Novel Mushroom-Derived Cytotoxin, Administered for Five Consecutive Days Every Four Weeks in Patients With Advanced Solid Malignancies

2000 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (47)
Phase I a nd P harmacokinetic S tudy o f t he O ral Fluoropyrimidine C apecitabine i n C ombination W ith Paclitaxel i n P atients W ith A dvanced S olid M alignancies

1999
Show All
- Source
- Cite
- Save
Citations (0)
Alternative Dosing Schedules for Irinotecan

1998 Oncology
Show All
- Source
- Cite
- Save
Citations (12)
Phase I trial of paclitaxel and gemcitabine administered every two weeks in patients with refractory solid tumors

1998 Annals of Oncology
Show All
- Source
- Cite
- Save
Citations (78)
Phase I and pharmacokinetic study of the water-soluble dolastatin 15 analog LU103793 in patients with advanced solid malignancies.

1998 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (31)